Literature DB >> 17539720

RANKL upregulation associated with periodontitis and Porphyromonas gingivalis.

Nawarat Wara-aswapati1, Rudee Surarit, Anek Chayasadom, Jason A Boch, Waranuch Pitiphat.   

Abstract

BACKGROUND: Receptor activator of nuclear factor-kappa B (NF-kappaB) ligand (RANKL) and osteoprotegerin (OPG) are critical for homeostatic control of osteoclast activity, suggesting their vital roles in the progression of bone loss in periodontitis. In this study, the expression of RANKL and OPG mRNA and the relationship between these factors and periodontopathic bacteria in periodontal tissue were studied.
METHODS: Gingival tissue and subgingival plaque samples were collected from 15 patients with chronic periodontitis and 15 periodontally healthy subjects. RNA was extracted from the tissue and subjected to reverse transcription-polymerase chain reaction (RT-PCR) using primers specific for RANKL or OPG. Beta-actin was amplified as a control to ensure equal loading. The intensity of RT-PCR products was analyzed by a densitometer in proportion to the intensity of beta-actin. The numbers of Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans were determined by quantitative real-time PCR.
RESULTS: Our results showed increased levels of RANKL mRNA in chronic periodontitis tissues. The RANKL/OPG expression ratio was significantly higher in the periodontitis group compared to the healthy control group (P = 0.001). Interestingly, the expression of RANKL (r = 0.64; P <0.001), but not OPG (r = -0.24; P = 0.20), was significantly correlated with increased numbers of P. gingivalis. A. actinomycetemcomitans was detected in only 6.7% of all sites.
CONCLUSIONS: Chronic periodontitis was associated with RANKL mRNA upregulation and increased RANKL/OPG mRNA expression ratio. In addition, our data showed for the first time to our knowledge an association between upregulated RANKL levels and the number of P. gingivalis in clinically obtained periodontal tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17539720     DOI: 10.1902/jop.2007.060398

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  18 in total

1.  Adjunctive effect of antimicrobial photodynamic therapy in induced periodontal disease. Animal study with histomorphometrical, immunohistochemical, and cytokine evaluation.

Authors:  Paula Gabriela Faciola Pessôa de Oliveira; Adriana Maria Mariano Silveira E Souza; Arthur Belém Novaes; Mário Taba; Michel Reis Messora; Daniela Bazan Palioto; Márcio Fernando Moraes Grisi; Antônio Cláudio Tedesco; Sérgio Luis Scombatti de Souza
Journal:  Lasers Med Sci       Date:  2016-06-28       Impact factor: 3.161

Review 2.  Toll gates to periodontal host modulation and vaccine therapy.

Authors:  George Hajishengallis
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

3.  Porphyromonas gingivalis infection-associated periodontal bone resorption is dependent on receptor activator of NF-κB ligand.

Authors:  Xiaozhe Han; Xiaoping Lin; Xiaoqian Yu; Jiang Lin; Toshihisa Kawai; Karen B LaRosa; Martin A Taubman
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

4.  Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis.

Authors:  Hiroyuki Kanzaki; Seicho Makihira; Maiko Suzuki; Takenobu Ishii; Alexandru Movila; Josefine Hirschfeld; Hani Mawardi; Xiaoping Lin; Xiaozhe Han; Martin A Taubman; Toshihisa Kawai
Journal:  J Immunol       Date:  2016-10-07       Impact factor: 5.422

5.  Role of osteoclasts in oral homeostasis and jawbone diseases.

Authors:  Maiko Omi; Yuji Mishina
Journal:  Oral Sci Int       Date:  2020-07-21

6.  OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.

Authors:  Takenobu Ishii; Montserrat Ruiz-Torruella; Atsushi Ikeda; Satoru Shindo; Alexandru Movila; Hani Mawardi; Abdullah Albassam; Rayyan A Kayal; Ayman A Al-Dharrab; Kenji Egashira; Wichaya Wisitrasameewong; Kenta Yamamoto; Abdulghani I Mira; Kenji Sueishi; Xiaozhe Han; Martin A Taubman; Takeshi Miyamoto; Toshihisa Kawai
Journal:  FASEB J       Date:  2018-03-13       Impact factor: 5.191

7.  RANKL and OPG mRNA level after non-surgical periodontal treatment.

Authors:  Xanthippi E Dereka; Cleopatra E Markopoulou; Galinos Fanourakis; Sofia Tseleni-Balafouta; Ioannis A Vrotsos
Journal:  Inflammation       Date:  2010-06       Impact factor: 4.092

8.  Host-bacteria crosstalk at the dentogingival junction.

Authors:  M T Pöllänen; M A Laine; R Ihalin; V-J Uitto
Journal:  Int J Dent       Date:  2012-07-26

Review 9.  The role of osteoimmunology in periodontal disease.

Authors:  Rayyan A Kayal
Journal:  Biomed Res Int       Date:  2013-09-17       Impact factor: 3.411

10.  AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression.

Authors:  J A Cirelli; C H Park; K MacKool; M Taba; K H Lustig; H Burstein; W V Giannobile
Journal:  Gene Ther       Date:  2008-12-11       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.